Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diazepam lipocalin imitating antibody

A technology of imitating antibodies and antibodies, applied in the direction of peptides, DNA/RNA fragments, specific peptides, etc., which can solve the problems of no reports of diazepam-mimicking antibodies and few small-molecule antibodies.

Inactive Publication Date: 2015-10-28
INST OF HYGIENE & ENVIRONMENTAL MEDICINE PLA ACAD OF MILITARY MEDICAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are relatively few studies on the screening of small molecule antibodies using ribosome display technology, and the screening of diazepam analog antibodies has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diazepam lipocalin imitating antibody
  • Diazepam lipocalin imitating antibody
  • Diazepam lipocalin imitating antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Scalability identification of lipocalin mimic antibody library:

[0019] Using the biletriene-binding protein (BBP), a member of the lipocalin family, as the backbone, 16 mutation sites were randomly introduced to construct a lipocalin ribosome display library. Using the constructed lipocalin library as a template and using T7F and PDR as upstream and downstream primers for PCR amplification, the target band is about 900bp.

[0020] The T7 fragment was amplified from the pET32a plasmid by upstream and downstream primers T7F and RT7 as figure 1 As shown in (A), use primers PDF and PDR to amplify the T20-V109 sequence in the shell protein D of Lambda phage as the spacer sequence (ie, the P segment), such as figure 1 (B) shown. It can be seen from the figure that the target bands appear at 102bp and 300bp, which are consistent with the size of the T7 fragment and the P protein gene fragment, indicating that the amplification is successful. Through the upstream primer FB...

Embodiment 2

[0028] Screening of mimetic antibody against diazepam lipocalin

[0029] 1 In vitro transcription and translation

[0030] In vitro transcription and translation use Promega's E.coli S30 (Escherichia coli S30Extract System) linear template system, which couples transcription and translation.

[0031] 2 solid phase screening

[0032] (1) Coating: After the ELISA plate was soaked and dried in DEPC water, take the coupled complete antigen DZP-OVA / DZP-BSA, dilute it to 10 μg / mL with carbonate buffer, add 200 μL to each well, Incubate at 4°C for 8h.

[0033] (2) The next day, pour off the coating solution, wash the coated wells with sterilized PBS 3 times, each time for 3 minutes; then add 200 μL of blocking solution (0.5% BSA or 1% OVA) to the coated wells ), closed for 1h. Pour off the blocking solution, wash with PBS twice, each time for 2min, and then wash twice with pre-cooled WBT (150mmol / L NaCl, 50mmol / L Tris-acetate pH7.5, 0.1%Tween, 50mmol / L magnesium acetate) , each ...

Embodiment 3

[0047] Identification of diazepam-lipocalin mimetic antibody after five rounds of screening

[0048] The plasmid pMD18-T-BBP was extracted after culturing the completely correct sequenced strain, and then subjected to double enzyme digestion to obtain the BBP fragment containing the enzyme cleavage site. The enzyme cleavage reaction system was the same as before.

[0049] figure 2 It is shown that after each round of screening, EDTA dissociates the mRNA from the triplex complex, reverses with PM as a primer, and obtains cDNA, and then amplifies the mock antibody fragment with FBBP and Rtail as primers. After identification by 1.5% agarose gel electrophoresis, a target band can be seen at a size of about 500bp. After it was recovered and connected with the ribosome display element, a 900bp library for the next round of screening was obtained. figure 2 It is the identification map after five rounds of screening for the target small molecule diazepam from the mock antibody li...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention discloses a diazepam lipocalin imitating antibody, wherein the DNA sequence expressing the antibody is the sequence represented by SEQ ID NO.1 in the sequence table. According to the present invention, with the diazepam lipocalin imitating antibody, the foundation is established for rapid diazepam detection; in lipocalin, the encapsulation efficiency of the recognition sites capable of interacting with target molecules is up to 95% while the encapsulation efficiency of the binding sites within the antibody molecule is only 66%, wherein the large mutual contact surface (Ingo, 2003) capable of binding with target molecules exists in the lipocalin molecule so as to cause the previous conditions; and the lipocalin has characteristics of simple structure, small molecular weight, large recognition sites capable of binding with target molecules and stable skeleton, and has unique advantages compared with the antibody.

Description

technical field [0001] The invention relates to a diazepam mimetic antibody. Belonging to the field of biotechnology, the simulated antibody can be used to develop an immunoassay kit for rapid detection of diazepam residues. Background technique [0002] Diazepam (Diazepam, DZP), alias stability or benzodiazepine, chemical name 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepam Azepine-2-one, molecular formula C 16 h 13 ClN 2 O, molecular weight 284.76. It belongs to the long-acting benzodiazepine anxiolytics, which have anti-anxiety, sedative, hypnotic, anticonvulsant, antiepileptic, skeletal muscle relaxation and memory elimination effects. Widely used in clinical medicine, long-term use has addiction and dependence. Diazepam is a prohibited product in the country and is only sold as a prescription drug. It has sedative and hypnotic effects. Criminals often use this feature of DZP to commit crimes and cause great social harm. Moreover, poisoning and acciden...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/44C12N15/11
Inventor 宁保安高志贤孙思明彭媛白家磊
Owner INST OF HYGIENE & ENVIRONMENTAL MEDICINE PLA ACAD OF MILITARY MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com